Abstract:Acute myocarditis encompasses a diverse presentation of inflammatory cardiomyopathies with infectious and non-infectious triggers. The clinical presentation is heterogeneous, from subtle symptoms like mild chest pain to life-threatening fulminant heart failure requiring urgent advanced hemodynamic support. This review provides a comprehensive overview of the current state of knowledge regarding the pathogenesis, diagnostic approach, management strategies, and directions for future research in acute myocarditis. The pathogenesis of myocarditis involves interplay between the inciting factors and the subsequent host immune response. Infectious causes, especially cardiotropic viruses, are the most frequently identified precipitants. However, autoimmune processes independent of microbial triggers, as well as toxic myocardial injury from drugs, chemicals or metabolic derangements also contribute to the development of myocarditis through diverse mechanisms. Furthermore, medications like immune checkpoint inhibitor therapies are increasingly recognized as causes of myocarditis. Elucidating the nuances of viral, autoimmune, hypersensitivity, and toxic subtypes of myocarditis is key to guiding appropriate therapy. The heterogeneous clinical presentation coupled with non-specific symptoms creates diagnostic challenges. A multifaceted approach is required, incorporating clinical evaluation, electrocardiography, biomarkers, imaging studies, and endomyocardial biopsy. Cardiovascular magnetic resonance imaging has become pivotal for non-invasive assessment of myocardial inflammation and fibrosis. However, biopsy remains the gold standard for histological classification and definitively establishing the underlying etiology. Management relies on supportive care, while disease-specific therapies are limited. Although some patients recover well with conservative measures, severe or fulminant myocarditis necessitates aggressive interventions such as mechanical circulatory support devices and transplantation. While immunosuppression is beneficial in certain histological subtypes, clear evidence supporting antiviral or immunomodulatory therapies for the majority of acute viral myocarditis cases remains insufficient. Substantial knowledge gaps persist regarding validated diagnostic biomarkers, optimal imaging surveillance strategies, evidence-based medical therapies, and risk stratification schema. A deeper understanding of the immunopathological mechanisms, rigorous clinical trials of targeted therapies, and longitudinal outcome studies are imperative to advance management and improve the prognosis across the myocarditis spectrum.

Biomarkers for Myocarditis and Inflammatory Cardiomyopathy

The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy

The inflammatory spectrum of cardiomyopathies

Acute myocarditis: an overview of pathogenesis, diagnosis and management

Immune-related biomarkers in myocardial infarction; diagnostic/prognostic value and therapeutic potential

Immunopathogenesis and immunomodulatory therapy for myocarditis

The Biomarkers for Acute Myocardial Infarction and Heart Failure.

Viral myocarditis: From molecular mechanisms to therapeutic prospects

What are the early warning signs of myocarditis during the pathway of care?

Inflammation—A Possible Link between Myocarditis and Arrhythmogenic Cardiomyopathy

Abstract 14265: Proteomic Discovery of Molecular Pathways in Patients With Biopsy-Proven Myocarditis

Immune checkpoint inhibitor-related myocarditis: current understanding and potential diagnostic and therapeutic strategies

Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure

Innate and adaptive immunity in acute myocarditis

The Roles of Cardiac Fibroblasts and Endothelial Cells in Myocarditis

Myocarditis and autoimmunity

Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis

Molecular mechanisms promoting progression of autoimmune myocarditis to dilated cardiomyopathy.

Myocarditis in connective tissue diseases: an often-overlooked clinical manifestation

Crosstalk Between Innate Immunity and Autophagy in Viral Myocarditis Leading to Dilated Cardiomyopathy

Myocarditis: A multi-omics approach